Eleonora Rofi
Pisa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC.
Journal: Cancer immunology, immunotherapy : CII
Published: July 02, 2020
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel.
Journal: The pharmacogenomics journal
Published: April 20, 2020
Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring.
Journal: Neuro-oncology
Published: September 11, 2019
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy.
Journal: Cancer chemotherapy and pharmacology
Published: June 14, 2019
Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA.
Journal: Clinical lung cancer
Published: June 14, 2019
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients.
Journal: Breast cancer research and treatment
Published: May 18, 2019
Androgen receptor (AR) splice variant 7 and full-length AR expression is associated with clinical outcome: a translational study in patients with castrate-resistant prostate cancer.
Journal: BJU international
Published: May 06, 2019
Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers.
Journal: Critical reviews in oncology/hematology
Published: April 22, 2019
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers.
Journal: Critical reviews in oncology/hematology
Published: April 22, 2019
Last Updated: 09/26/2026